Cargando…

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (SICD) is effective therapy for sudden cardiac death prevention. The condition for implantation is an electrocardiographic screening test before procedure (ECG-s). Patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, M, Syska, P, Kowalik, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207667/ http://dx.doi.org/10.1093/europace/euad122.423

Ejemplares similares

Perioperative and postoperative pain in patients undergoing subcutaneous implantable cardioverter-defibrillator placement
por: Bisignani, A, et al.
Publicado: (2023)

A 25-year single-center experience with transvenous and subcutaneous ICD patients under thirty years of age
por: Lewandowski, M, et al.
Publicado: (2023)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Intermuscular two-incision technique for implantation of the subcutaneous implantable defibrillator: 3-year follow-up
por: Migliore, F, et al.
Publicado: (2023)

Gender-specific differences in young patients receiving implantable cardioverter-defibrillator therapy - a subgroup analysis of the german device registry
por: Schlichting, A, et al.
Publicado: (2023)

Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
por: Cabrera Borrego, E, et al.
Publicado: (2023)

A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation
por: Lopez Perales, C, et al.
Publicado: (2023)

Defibrillation testing during S-ICD implantation: How relevant? Results from a multicenter study
por: Ben Kilani, M, et al.
Publicado: (2023)

Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices
por: Som, Z, et al.
Publicado: (2023)

Clinical predictors of very low defibrillation threshold in the extravascular ICD
por: Murgatroyd, F, et al.
Publicado: (2023)

Post-shock acute electrical parameters of left bundle branch area defibrillation (LBBAD) leads
por: Huybrechts, W, et al.
Publicado: (2023)

Long term longevity of defibrillator leads: a prospective follow-up over 25 years
por: Davril, C, et al.
Publicado: (2023)

A tertiary centre experience of routine exercise testing as part of subcutaneous ICD vector mapping
por: Hall, P, et al.
Publicado: (2023)

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
por: De Veld, J A, et al.
Publicado: (2023)

Impact of gender on the utilization of cardiac implantable devices and outcome: results from the German DEVICE registry
por: Popescu, S S, et al.
Publicado: (2023)

Amiodarone does not significantly affect the success rate of ventricular fibrillation induction tests performed during or after ICD implantation. Insights from the German DEVICE registry
por: Wiedmann, F, et al.
Publicado: (2023)

Validation of a transthoracic impendance sensor for screening of sleep apnea in CIED patients: a pooled analysis of AIRLESS and UPGRADE
por: Barbieri, F, et al.
Publicado: (2023)

Beneficial effects of high output His bundle pacing in patients with heart failure, narrow QRS
por: Katsouras, G, et al.
Publicado: (2023)

Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
por: Martignani, C, et al.
Publicado: (2023)

Do co-morbidities, frailty and functional status identify patients who may not benefit from ICD therapy?
por: Wilson, D G, et al.
Publicado: (2023)

ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
por: Kleemann, T, et al.
Publicado: (2023)

Evaluation of MADIT II risk stratification score among registry of heart failure patients with primary prevention ICD/CRTD device
por: Rav Acha, M, et al.
Publicado: (2023)

Trends in adoption of extravascular devices compared to conventional devices: real-world data from the Netherlands Heart Registration
por: Breeman, K T N, et al.
Publicado: (2023)

Capsulectomy: a safe and effective way to lower shock impedance in S-ICD replacement procedures
por: Wuerfel, S, et al.
Publicado: (2023)

Quality improvements anticipated by guideline adherence to peri-operative ICD deactivation
por: Finnerty, D, et al.
Publicado: (2023)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Facteurs associés à l'infection au SARS-CoV-2 à Tunis après la deuxième vague épidémique
por: Cherif, I., et al.
Publicado: (2022)

Real‐world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
por: Baalman, Sarah W.E., et al.
Publicado: (2020)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7983flf2g77lk9d018ldnmeqnq